secwatch.observer — SEC 8-K summary
======================================

Issuer:     Varex Imaging Corp (VREX)
CIK:        0001681622
Form:       8-K
Filed at:   2024-11-19T23:59:59+00:00
Accession:  0001681622-24-000088
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Varex Q4 FY24 revenue $206M; GAAP EPS loss $1.22, non-GAAP EPS $0.19
--------------------------------------------------------------------

- GAAP net loss of $1.22 per diluted share; non-GAAP EPS of $0.19, down from $0.45 YoY.
- Total revenue $206M in Q4 FY24, down 10% YoY; full-year revenue $811M.
- Medical segment revenue $144M (-12% YoY); Industrial $61M (-4% YoY).
- Ended FY24 with $213M cash and marketable securities; operating cash flow $26M in Q4.
- Q1 FY25 guidance: revenue $195-215M, non-GAAP EPS -$0.05 to $0.10.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1681622/000168162224000088/0001681622-24-000088-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1681622/000168162224000088/vrex-20241119.htm
  HTML page:      https://secwatch.observer/filing/0001681622-24-000088

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer